National Heart, Lung and Blood Institute, Cystic Fibrosis Foundation, CF Therapeutics Development Network Coordinating Center. Comparison of two treatment regimens to reduce PA infection in children with cystic fibrosis (EPIC). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of ...
We are grateful to the Cystic Fibrosis Foundation (Bethesda, MD) for kindly providing the CRISPR/Cas9 gene edited 16HBE14o-, W1282X-CFTR and G542X-CFTR cell lines, to Dr. J.R. Riordan (University of North Carolina, Chapel Hill) for anti-CFTR ab596 and ab570 (Cystic Fibrosis Foundatio...
” said Robert J. Beall, Ph.D., president and chief executive officer of the Cystic Fibrosis Foundation in Bethesda, Md. “We look forward to the next stage of clinical development to demonstrate the benefits of this promising therapy
企业注册号: FN010203 成立日期: 1987-01-23 企查查编码: QUSFMAUG8F 办公地址: 4550 MONTGOMERY AVE STE 1100N BETHESDA, MD 20814-5269 USA 基本信息 企业注册号 FN010203 企业名称 CYSTIC FIBROSIS FOUNDATION 企业状态 GOOD STANDING 成立日期 1987-01-23 ...
1. Cystic Fibrosis Foundation Patient Registry: Annual Data Report 2010. Bethesda, MD: Cystic Fibrosis Foundation; 2011. 2. Human Genome Project. CFTR: the gene associated with cystic fibrosis. www.ornl.gov/sci/techresources/Human_Genome/posters/chromosome/cftr.shtml. Accessed October 20, 2012....
Cystic Fibrosis Foundation patient registry 2019 annual data report. Bethesda: Cystic Fibrosis Foundation; 2019. Griesenbach U, Alton EW. Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction. F1000prime Rep. 2015;7:64. Article PubMed PubMed Central...
Cystic Fibrosis Foundation. CFF Patient Registry, Bethesda, Maryland, 2005. Hardin DS, LeBlanc A, Lukenbough S, Seilheimer DK . Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr 1997; 130: 948–956. Article CAS PubMed Google Scholar Lanng S . Diabe...
Foundation Cystic Fibrosis Cystic Fibrosis Foundation Patient Registry 2007 Annual Data Report, Cystic Fibrosis Foundation, Bethesda, MD (2008) Google Scholar [16] H.J. Fuchs, D.S. Borowitz, D.H. Christiansen, E.M. Morris, M.L. Nash, B.W. Ramsey, et al. Effect of aerosolized recombinant...
In a ground-breaking program funded by the Cystic Fibrosis Foundation (Bethesda, USA), a nonprofit, donor-supported organization, Vertex Pharmaceuticals identified 13 distinct chemical scaffolds with CFTR corrector activity after screening ~164 000 chemically diverse drug-like small molecules[55]. Fol-...
The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. The Foundation funds more CF research than any other organization and nearly every CF drug available today was made possible because of Foundation support. Based in Bethesda, Md., the Foundation ...